Patents Assigned to Laboratoire Chauvin S.A.
  • Publication number: 20060016739
    Abstract: The invention concerns an anti-microbial porous part based on a polymeric material grafted at the surface and in its volume with ammonium motifs with anti-microbial and/or bactericidal and/or fungicide activity, preferably benzalkonium. The invention is characterized in that it has a porosity sufficiently high to enable a liquid with compatible viscosity to pass through its structure and sufficiently low to trap contaminating germs within said structure.
    Type: Application
    Filed: September 19, 2005
    Publication date: January 26, 2006
    Applicant: Laboratoire Chauvin S.A.
    Inventors: Mohammed Naji, Bernard Pages, Jacques Lacombe
  • Patent number: 6986429
    Abstract: The invention concerns an anti-microbial porous part based on a polymeric material grafted at the surface and in its volume with ammonium motifs with anti-microbial and/or bactericidal and/or fungicide activity, preferably benzalkonium. The invention is characterized in that it has a porosity sufficiently high to enable a liquid with compatible viscosity to pass through its structure and sufficiently low to trap contaminating germs within said structure.
    Type: Grant
    Filed: April 26, 2001
    Date of Patent: January 17, 2006
    Assignee: Laboratoire Chauvin S.A.
    Inventors: Mohammad Naji, Bernard Pages, Jacques Lacombes
  • Patent number: 6399605
    Abstract: The invention concerns an ophthalmic composition comprising a beta-blocker solution, said composition being obtained by dissolving in water beta-blocker in the presence of alginic acid and adding an alkaline base, to obtain a solution with the PH of 6 to 8. Said composition has a sustained duration of action.
    Type: Grant
    Filed: December 28, 2000
    Date of Patent: June 4, 2002
    Assignee: Laboratoire Chauvin S.A.
    Inventors: Florence Maurin, Elisabeth Latour, Claude Coquelet
  • Patent number: 5770596
    Abstract: The subject of this invention is a ready-for-use collyrium intended for the treatment of ocular allergies, comprising, in aqueous solution, mequitazine and a .beta.- or a .gamma.-cyclodextrin optionally etherified by C.sub.1 -C.sub.4 alkyl or C.sub.1 -C.sub.4 hydroxyalkyl groups, the said cyclodextrin being present in at least a molar ratio of at least one in relation to mequitazine.
    Type: Grant
    Filed: December 5, 1996
    Date of Patent: June 23, 1998
    Assignee: Laboratoire Chauvin S.A.
    Inventors: Claude Coquelet, Elisabeth Latour, Florence Maurin
  • Patent number: 5744154
    Abstract: The present invention relates to a ready-to-use indomethacin eye lotion comprising, in aqueous solution:indomethacin,a .beta.- or .gamma.-cyclodextrin etherified with C.sub.1 -C.sub.4 alkyl or C.sub.1 -C.sub.4 hydroxyalkyl groups, the cyclodextrin being present in a molar ratio with respect to the indomethacin of at least 10/1, and the pH of the solution being from 4.0 to 6.0.
    Type: Grant
    Filed: September 4, 1996
    Date of Patent: April 28, 1998
    Assignee: Laboratoire Chauvin S.A.
    Inventors: Florence Maurin, Bernard Pages, Claude Coquelet
  • Patent number: 5270050
    Abstract: The object of the invention is an ophthalmic composition containing between 0.1 to 10% by weight of paracetamol in an ophthalmic excipient.
    Type: Grant
    Filed: November 12, 1991
    Date of Patent: December 14, 1993
    Assignee: Laboratoire Chauvin S.A.
    Inventors: Claude Coquelet, Claude Bonne, Elisabeth Latour